ZOTA HEALTH CARE
|
ZOTA HEALTH CARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -2.29 | 3.54 | -0.09 | 1.12 | 3.16 |
| CEPS(Rs) | 2.46 | 5.00 | 1.21 | 1.97 | 2.83 |
| DPS(Rs) | 1.00 | 1.50 | 1.00 | 1.00 | 1.00 |
| Book NAV/Share(Rs) | 31.94 | 35.62 | 26.99 | 28.02 | 39.29 |
| Tax Rate(%) | -23.06 | 28.37 | 42.83 | 29.00 | 29.37 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.76 | 11.00 | 0.54 | 4.74 | 9.04 |
| EBIT Margin(%) | -1.52 | 9.72 | -0.24 | 4.13 | 9.22 |
| Pre Tax Margin(%) | -3.35 | 9.48 | -0.34 | 4.06 | 9.17 |
| PAT Margin (%) | -4.12 | 6.79 | -0.20 | 2.88 | 6.48 |
| Cash Profit Margin (%) | 4.42 | 9.59 | 2.77 | 5.09 | 8.11 |
| Performance Ratios | |||||
| ROA(%) | -3.90 | 7.94 | -0.24 | 3.08 | 6.19 |
| ROE(%) | -6.79 | 11.43 | -0.31 | 3.98 | 8.05 |
| ROCE(%) | -2.50 | 16.36 | -0.38 | 5.71 | 11.45 |
| Asset Turnover(x) | 0.95 | 1.17 | 1.23 | 1.07 | 0.96 |
| Sales/Fixed Asset(x) | 1.99 | 3.37 | 3.68 | 3.93 | 4.21 |
| Working Capital/Sales(x) | 3.21 | 3.20 | 2.48 | 2.36 | 2.01 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.50 | 0.30 | 0.27 | 0.25 | 0.24 |
| Receivable days | 83.71 | 90.61 | 98.96 | 98.30 | 94.19 |
| Inventory Days | 92.24 | 79.46 | 91.46 | 111.01 | 138.59 |
| Payable days | 98.97 | 72.26 | 76.17 | 85.77 | 103.51 |
| Valuation Parameters | |||||
| PER(x) | - | 84.06 | - | 116.69 | 58.65 |
| PCE(x) | 114.63 | 59.53 | 114.93 | 66.11 | 65.62 |
| Price/Book(x) | 8.82 | 8.35 | 5.13 | 4.65 | 6.61 |
| Yield(%) | 0.35 | 0.50 | 0.72 | 0.77 | 0.39 |
| EV/Net Sales(x) | 5.06 | 5.69 | 3.17 | 3.35 | 5.30 |
| EV/Core EBITDA(x) | 76.17 | 45.44 | 179.81 | 52.93 | 48.88 |
| EV/EBIT(x) | -332.66 | 58.52 | -1,325.56 | 81.17 | 57.51 |
| EV/CE(x) | 4.51 | 5.37 | 3.96 | 3.61 | 5.07 |
| M Cap / Sales | 5.07 | 5.71 | 3.19 | 3.36 | 5.32 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 6.67 | 22.86 | 12.25 | 11.07 | - |
| Core EBITDA Growth(%) | -43.44 | 771.77 | -68.74 | -35.09 | - |
| EBIT Growth(%) | -116.68 | 5,090.41 | -106.50 | -50.19 | - |
| PAT Growth(%) | -164.81 | 4,364.05 | -107.62 | -50.59 | - |
| EPS Growth(%) | -164.81 | 4,262.36 | -107.62 | -64.71 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.08 | 2.14 | 3.36 | 3.17 | 3.15 |
| Quick Ratio(x) | 1.05 | 1.33 | 1.81 | 1.80 | 1.51 |
| Interest Cover(x) | -0.83 | 39.77 | -2.33 | 56.64 | 214.47 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of ZOTA HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZOTA HEALTH CARE | ₹1,276.0 Cr | 2.4% | -12.9% | 56.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
| CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
ZOTA HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZOTA HEALTH CARE | 2.4% |
-12.9% |
56.7% |
| SENSEX | -2.9% |
-0.4% |
20% |
You may also like the below Video Courses
